Cytokinetics (CYTK) Receivables (2016 - 2025)
Historic Receivables for Cytokinetics (CYTK) over the last 9 years, with Q3 2024 value amounting to $244000.0.
- Cytokinetics' Receivables fell 9023.61% to $244000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $244000.0, marking a year-over-year decrease of 9023.61%. This contributed to the annual value of $1.3 million for FY2023, which is 77278.91% up from last year.
- Cytokinetics' Receivables amounted to $244000.0 in Q3 2024, which was down 9023.61% from $834000.0 recorded in Q1 2024.
- In the past 5 years, Cytokinetics' Receivables ranged from a high of $51.8 million in Q4 2021 and a low of $147000.0 during Q4 2022
- In the last 5 years, Cytokinetics' Receivables had a median value of $2.3 million in 2020 and averaged $5.1 million.
- Its Receivables has fluctuated over the past 5 years, first soared by 107237.56% in 2021, then plummeted by 9971.63% in 2022.
- Quarter analysis of 5 years shows Cytokinetics' Receivables stood at $4.4 million in 2020, then skyrocketed by 1072.38% to $51.8 million in 2021, then plummeted by 99.72% to $147000.0 in 2022, then skyrocketed by 772.79% to $1.3 million in 2023, then plummeted by 80.98% to $244000.0 in 2024.
- Its Receivables was $244000.0 in Q3 2024, compared to $834000.0 in Q1 2024 and $1.3 million in Q4 2023.